The global nalbuphine hydrochloride market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Nalbuphine HCL (Nalbuphine hydrochloride) or commonly known as nubain, belongs to a group of opioid analgesics, is a narcotic pain reliever used to treat moderate to severe pain as well as treats opioid addiction. Adding to this, nubain is also used in treatment of pain just after childbirth or surgery. Thus, the growing application of the drug is anticipated to provide a boost to the market growth. Another major factor likely to propel the market growth includes the widespread regulatory approval and efficacy, with considerably less capacity for euphoria or any respiratory depression in comparison to other opioids. This attribute of the drug has made it convenient for the drug suppliers and manufacturers to commercialize it under various company brand names including Mexifen, Nalbuphine, Nalpain, Kinz, Nalufin, Raltrox, Rubuphine, Nalbin, Analin, and Exnal, among others.

The global nalbuphine hydrochloride market is segmented based on type and application. On the basis of type, the market is sub segmented into adult and children. Among both these types, the adult segment is likely to show a prominent growth owing to a comparatively higher demand. Since the medicine is a composition of narcotic pain reliever, it is only recommended to children in exclusively severe medical conditions. Whereas on the basis of application, the market is further segmented into hospital, pharmacy, and others. Among all of these, the pharmacy sub segment is anticipated to hold a substantial market share, owing to the significant demand for the drug attributed to its widespread regulatory approval and efficacy.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type

o By Application

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape:  Glenmark Pharmaceuticals Ltd., Pfizer Inc., and Abbott Laboratories, among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Nalbuphine Hydrochloride Market Report by Segment

By Type

    • Adult

    • Children

By Application

    • Hospital

    • Pharmacy

    • Others

Global Nalbuphine Hydrochloride Market by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa